• 제목/요약/키워드: hematological examination

검색결과 161건 처리시간 0.032초

Frequency of anemia and micronutrient deficiency among children with cleft lip and palate: a single-center cross-sectional study from Uttarakhand, India

  • Chattopadhyay, Debarati;Vathulya, Madhubari;Naithani, Manisha;Jayaprakash, Praveen A;Palepu, Sarika;Bandyopadhyay, Arkapal;Kapoor, Akshay;Nath, Uttam Kumar
    • 대한두개안면성형외과학회지
    • /
    • 제22권1호
    • /
    • pp.33-37
    • /
    • 2021
  • Background: Children with cleft lip and/or palate can be undernourished due to feeding difficulties after birth. A vicious cycle ensues where malnutrition and low body weight precludes the child from having the corrective surgery, in the absence of which the child fails to gain weight. This study aimed to identify the proportion of malnutrition, including the deficiency of major micronutrients, namely iron, folate and vitamin B12, in children with cleft lip and/or palate and thus help in finding out what nutritional interventions can improve the scenario for these children. Methods: All children less than 5 years with cleft lip and/or cleft palate attending our institute were included. On their first visit, following were recorded: demographic data, assessment of malnutrition, investigations: complete blood count and peripheral blood film examination; serum albumin, ferritin, iron, folate, and vitamin B12 levels. Results: Eighty-one children with cleft lip and/or palate were included. Mean age was 25.37±21.49 months (range, 3-60 months). In 53% of children suffered from moderate to severe wasting, according to World Health Organization (WHO) classification. Iron deficiency state was found in 91.6% of children. In 35.80% of children had vitamin B12 deficiency and 23.45% had folate deficiency. No correlation was found between iron deficiency and the type of deformity. Conclusion: Iron deficiency state is almost universally present in children with cleft lip and palate. Thus, iron and folic acid supplementation should be given at first contact to improve iron reserve and hematological parameters for optimum and safe surgery.

Hypoadrenocorticism in a 1-Year-Old Korean Shorthair Cat

  • Jung, Hansol;Jeong, Yunho;Kim, Yoonhwan;Choi, Sooyoung;Park, Inchul;Ahn, Jin-Ok
    • 한국임상수의학회지
    • /
    • 제39권3호
    • /
    • pp.144-148
    • /
    • 2022
  • A one-year-old spayed female Korean Shorthair cat presented to Kangwon National University Veterinary Hospital with vomiting, weight loss, lethargy, loss of appetite, and polyuria that lasted for more than two weeks. The body condition score, blood pressure, heart rate, and body temperature were abnormally low, and the physical examination findings were consistent with moderate dehydration. Hematological and biochemical tests demonstrated mild azotemia and a low Na:K ratio. Additional abdominal ultrasound imaging revealed reduced size of both adrenal glands. The adrenocorticotropic hormone (ACTH) stimulation test showed decreased post-ACTH cortisol and aldosterone levels and increased endogenous ACTH levels, confirming a diagnosis of primary hypoadrenocorticism. The cat was treated with subcutaneous injections of desoxycorticosterone pivalate (DOCP) and oral prednisolone supplementation, and subsequent electrolyte analysis showed a normal Na:K ratio. Clinical symptoms were also improved in response to treatment. Hypoadrenocorticism in cats is a very rare disease, but it should not be excluded as a potential diagnosis in favor of kidney diseases or other conditions, especially when the Na:K ratio is low. In addition, the prognosis for the disease and the response to DOCP treatment should be further evaluated in cats.

Subchronic Toxicity of a Combined Preparation of Ticlopidine and Giekgo Biloba Extract Orally Administered to Rats for 30 Days

  • Kim, Sung Y.;Yim, Hye K.;Yoon, Mi Y.;Kim, Sang K.;Lee, Ja Y.;Oh, Soo J.;Kim, Hye S.;Kang, Sung A.;Kim, Young C.
    • Toxicological Research
    • /
    • 제14권4호
    • /
    • pp.547-555
    • /
    • 1998
  • The subchronic toxicity of a combined preparation of ticlopidine and ginkgo biloba extract (EGb 761) mixed in a ratio of 10: 4 was examined in male and female Sprague-Dawley rats. Rats were treated with the test substance at a dose of 52 mg/kg, 156 mg/kg, or 467 mg/kg intragastrically for 30 consecutive days. Control rats were treated with vehicle only. Each group consisted of 10 rats. No death or abnormal clinical signs were observed throughout the administration period. A transient decrease in body weight gain and food intake was observed in the rats treated with the high dose (467 mg/kg), which was recovered to normal in a week. There were no drug-related differences in urinalysis and hematological results. A significant increase in serum total cholesterol and total protein was observed in both sexes of the rats treated with a dose of 467 mg/kg daily, but all the other values obtained in serum chemistry appeared to be within normal range. A dose dependent increase in liver weight was observed in both male and female rats. Relative kidney weight was also increased in the high dose groups. There was no gross pathological finding at terminal sacrifice. Microscopic histopathological examination did not show any lesion in terms of correlation with administration of the test substance. The results suggest that under the conditions employed in this study no observable effect level (NOEL) of the test substance be 52 mg/kg/day.

  • PDF

Chronic Toxicity of a Combined Preparation of Ticlopidine and Ginkgo Biloba Extract (EGb 761) Orally Administered to Rats for 13 Consecutive Weeks

  • Kim, Sang K.;Kim, Sung Y.;Yoon, Mi Y.;Oh, Soo J.;Kim, Hye S.;Lee, Ja Y.;Kang, Sung A.;Lee, Kyung H.;Kim, Young C.
    • Toxicological Research
    • /
    • 제16권4호
    • /
    • pp.293-301
    • /
    • 2000
  • Toxicity of a combined preparation of ticlopidine and ginkgo biloba extract (EGb 761) in a ratio of 10: 4 was examined in male and female Sprague-Dawley rats. Rats were treated with the test substance intragastrically at a dose of 0 mg/kg, 17 mg/kg, 52 mg/kg or 156 mg/kg for 91 consecutive days. No death or abnormal clinical sign was observed throughout the administration period. There was no difference in body weight gain, food intake or water consumption among different dose groups. Test sub-stance-related differences were not observed in urinalysis. In hematological results mean corpuscular hemoglobin (MCH) of low and high dose male group was increased. Prothrombin time of medium and high dose female group was decreased. A significant increase in serum total cholesterol was observed in both sexes of rats treated with a daily dose of 156 mg/kg, but all the other values obtained in serum chemistry appeared to be within normal ranges. A dose dependent increase in the relative liver and kidney weights was observed in both male and female rats. There were no gross pathological findings at terminal sacrifice. Microscopic histopathological examination did not show any lesion associated with administration of the test substance. The results suggest that under the conditions employed in this study no observable effect level (NOEL) of the test substance be greater than 17 mg/kg/day, but less than 52 mg/kg/day.

  • PDF

Intralipidos에 대한 급성독성 및 4주간 정맥 내 반복투여 독성시험 (Acute Toxicity and Four-week Intravenous Toxicity Studies of Intralipidos)

  • 이광훈;제정환;강병철;이원우;임종희;정지윤;이병희;남정석;박재학;이영순
    • Toxicological Research
    • /
    • 제14권3호
    • /
    • pp.443-452
    • /
    • 1998
  • This sutdy was carried out to investigate the acute toxicity and foru-week intravenous toxicity of the intralipidos in rats and rabbits. The acute toxicity study of Intralipidos was performed in Spragur-Dawley (SD) rats. Intralipidos was administered by intravenous to maximum dose 200 ml/kg. $LD_{50}$ of intralipidos was found 139.5ml/kg and 153.8ml/kg in male female SD rats. Four-week toxicity of intralipidos using New Zealand White Rabbit and SD rats. The Rabbit and Rats were administered by intravenous seven days per week for 28 days, with dosage of 15, 6, 2 ml/kg/day and 20, 6, 2ml/kg/day, respectively. Animals treated with intralipidos did not cause any death and show any clinical signs. They did not show any significant changes of body weight, feed uptake and water consumption. They were not significantly different from the control group in urinalysis, ocular examination hematological, serum biochemical value and histopathological examination. Therefore, Intralipidos was not indicated to have any toxic effect in the Rabbits and Rats, when it was administrated by intravenous below the dosage 15ml/kg/day and 20 ml/kg/day for four weeks.

  • PDF

Balb/c 마우스에서 초과 추출물의 3주간 반복 경구투여 독성평가 (Evaluation of 3-week Repeated Dose Oral Toxicity on Amomum tsao-ko Extract in Balb/c Mice)

  • 박주형;조영락;고혜진;정원식;안은경;오준호;오좌섭
    • Journal of Applied Biological Chemistry
    • /
    • 제58권2호
    • /
    • pp.139-143
    • /
    • 2015
  • 본 연구는 다양한 효능을 지닌 초과(Amomum tsao-ko Crevost et Lemaire)의 안전한 이용을 위한 독성평가로 식품의약품안전처 고시 제2014-6호 '의약품등의 독성시험기준'에 맞는 독성시험법에 따라 Balb/c mouse를 이용하여 3주간 반복경구투여를 통해 초과의 안전성을 확인하고자 하였다. 3주간 반복 경구투여 후 체중, 장기중량 측정, 혈액분석 및 혈액생화학 검사를 실시하여 안전성을 확인 한 결과, 초과에 의한 특별한 증상이나 체중, 장기중량의 변화는 관찰되지 않았으며, 복대동맥으로부터 채혈한 혈액을 통한 혈구분석결과에서도 대조군과 초과 추출물 투여군 간의 통계적인 유의성을 관찰 할 수 없었다. 또한 혈청을 이용하여 간기능(GOT, GPT, LDH, ALB, TP-S, T-BIL, D-BIL), 신장기능(BUN, CRE), 지질영양 관련(TG), 전해질 관련(I.P) 지표들의 생화학분석을 수행한 결과, 대조군과 유사하게 모두 정상 범위 내의 결과를 나타내었다. 이러한 결과를 통하여 초과 추출물의 최대무독성용량은 최고 투여량인 2000 mg/kg 이상으로 판단되며, 본 연구결과는 초과의 기능성 식품, 화장품, 의약품 등 다양한 소재로서의 활용에 안전성 관련 기초자료로 이용될 수 있을 것으로 사료된다.

여우에서 피하지방종의 진단 (A Subcutaneous Lipoma in a Male Red Fox)

  • 정동혁;양정진;공주연;이배근;이제욱;박세진;이승용;석성훈;홍일화;이희천;연성찬
    • 한국임상수의학회지
    • /
    • 제32권3호
    • /
    • pp.278-281
    • /
    • 2015
  • 국립공원관리공단 종복원기술원의 수컷 여우(8년령, 8.5 kg)에서 경부에 결절상의 증식물이 발견되었다. 진단을 위하여 방사선 검사와 초음파, 일반혈액검사, 혈청 화학분석, 혈액 도말 검사를 실시하였고 증식물은 외과적으로 절제하였다. 절제술 후 얻은 조직 샘플을 10% 중성 포르말린 고정 후 HE 염색하였다. 해당 동물의 혈액 수치는 일반 여우와 크게 다르지 않았다 증식물은 육안으로 보았을 때 주변조직과 잘 구획되어 있었으며 둥글고 하얀 형태였다. 조직 슬라이드 현미경 검사 후 이는 성숙 지방 조직으로 이루어진 지방종으로 진단되었다. 지방종은 반려동물에서 흔히 발생하는 양성 종양이나 현재까지 여우에서는 보고된 적이 없으며, 이 증례는 여우에서 지방종을 종합적으로 진단 평가한 최초 증례이다.

시츄견에서 위유문부에서 발생한 위선종 증례 (Gastric Adenoma in the Pyloric Outflow Tract of a Shih-tzu Dog)

  • 이희천;권도형;문종현;김영기;조규완;강병택;임금순;서정향;정동인
    • 한국임상수의학회지
    • /
    • 제29권2호
    • /
    • pp.169-172
    • /
    • 2012
  • 12살의 중성화된 수컷 시츄견이 구토, 식욕부전, 체중감소의 증상으로 내원하였다. 병력청취, 혈액검사, 방사선검사, 초음파검사, 내시경검사가 진단을 위해 시행되었다. 병력청취에 따르면, 환자는 몇 주 전부터 만성신부전증 치료를 받고 있었다. 혈청화학검사에서 환자는 고질소혈증을 보였고 복부 방사선검사와 초음파검사에서 위의 유문부 종괴를 확인하였다. 위 내시경 검사에서는 유문방의 증식성 종괴가 관찰되었다. 내시경적 생검 후 조직병리학적 검사결과는 위선종이였고 이 결과에 따라 수술적 처치(유문 배출부위의 절제와 Y-U 유문성형술)를 실시하였다. 수술 후 두번째 조직병리학적 검사결과 또한 위선종이였다. 술 후, 환자는 점차 호전되었고, 임상증상은 술 후 3주 후 사라졌다. 환자의 상태는 현재까지 잘 유지되고 있다.

흰쥐에서 MIA로 유발된 골관절염에 선방활명음 가미방이 미치는 영향 (Effects of Sunbanghwalmyung-Eum Gamibang on MIA-Induced Osteoarthritis in Rats)

  • 신유빈;박한별;김재수;이현종;임성철;이윤규
    • Korean Journal of Acupuncture
    • /
    • 제39권4호
    • /
    • pp.152-171
    • /
    • 2022
  • Objectives : This study was designed to investigate the effects of Sunbanghwalmyung-eum gamibang on Monosodium iodoacetate-induced osteoarthritis rats. Methods : Forty Sprague-Dawley (SD) rats were divided into 5 groups of 8 rats each. Osteoarthritis (OA) was induced by injecting MIA (2 mg/50 µl) into the joint cavity of the left knee of SD rats belonging to the experimental group, and normal saline was injected into the joint cavity of the left knee instead of MIA in the normal group. To the normal group and the controlled group (OA group), 2 ml of distilled water was orally administered. To the positive control group (Indomethacin group), indomethacin 2 ml at a concentration of 2 mg/kg, to the low concentration group of SHG (Low group), 2 ml of SHG at a concentration of 2 mg/kg, and to the high concentration group of SHG (High group), 2 ml of SHG at a concentration of 4 mg/kg ml was orally administered. The drug was administered for a total of 4 weeks, and histological changes were analyzed by Hematoxylin-Eosin staining and Safranin-O staining. In addition, inflammatory cytokines such as TNF-α, IL-1β, and IL-6, and MMP-13, TIMP-1, and GAGs were immunohistochemically analyzed. Finally, hematological examination, blood biochemical examination, and liver and kidney biopsy were performed. Results : SHG groups (Low and High) inhibited the matrix destruction and damage of the knee joint cartilage in SD rat model, and significantly prevented the reduction in cartilage thickness. In SHG groups, the expressions of TNF-α, IL-1β, IL-6 and MMP-13 were significantly decreased, and the expressions of TIMP-1, GAGs were significantly increased compared with OA group. The safety indicators had no significant differences among five groups. Conclusions : These results show that SHG has cartilage protection capacity, anti-inflammatory effect.

제독유황에 대한 3개월간 랫드에서 반복경구투여 독성에 관한 연구 (Toxicity Study of Detoxication Sulphur at 3 Months Post-treatment in Rats)

  • 이진석;권중기;한상현;안인정;김소정;이성호;박영석;박병권;김병수;김상기;김일호;최창순;정지윤
    • 한국식품위생안전성학회지
    • /
    • 제25권3호
    • /
    • pp.263-268
    • /
    • 2010
  • 본 연구는 8주령 Sprague-Dawley계통의 암컷 랫드에서 제독유황을 반복경구투여 독성평가를 하기위해 시행하였다. 랫드에 처치한 물질은 사료섭취량의 0.2%, 1%, 5% 제독유황과 사료섭취량의 1% 유황으로 13주 경구투여를 하였다. 제독유황의 안전성을 확인하기 위해 다음과 같은 관찰 및 검사를 하였다. 검사항목으로는 체중과 사료 섭취를 측정하였고 임상증상, 안과학적 검사, 혈액학적 검사, 혈청 생화학적 검사를 관찰하였다. 또한 랫드에 간과 신장에서의 병리조직학적 변화를 관찰하였다. 그 결과 체중, 사료섭취량, 혈액학적 및 병리조직검사 소견에서 대조군과 제독유황 그룹 간의 유의적인 차이가 보이지 않았다. 혈청생화학적 검사소견에서는 0.2% 및 1% 투여군에서는 대조군과 비교시 용량의존적으로 유의적인 차이를 보이는 항목은 보이지 않았으나, 고용량군에서는 glucose 감소에 의한 저칼륨혈증, 인슐린 과잉분비의 독성을 의심할 수 있었으며, 또한 ALT와 ALP의 증가는 간 독성이나 간암, 황달의 유발이 의심되었다. 한편, 병리조직학적인 검사에서는 시험 전체군에서 대조군과 비교시 유의할만한 병리조직이상이 관찰되지 않았다. 따라서 본 연구에서는 사료섭취량 1%의 제독유황까지 투여는 랫드에서 독성을 나타내지 않는 것으로 사료된다.